These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19291796)

  • 1. Survivin minigene DNA vaccination is effective against neuroblastoma.
    Fest S; Huebener N; Bleeke M; Durmus T; Stermann A; Woehler A; Baykan B; Zenclussen AC; Michalsky E; Jaeger IS; Preissner R; Hohn O; Weixler S; Gaedicke G; Lode HN
    Int J Cancer; 2009 Jul; 125(1):104-14. PubMed ID: 19291796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.
    Huebener N; Fest S; Strandsby A; Michalsky E; Preissner R; Zeng Y; Gaedicke G; Lode HN
    Mol Cancer Ther; 2008 Jul; 7(7):2241-51. PubMed ID: 18645033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
    Croce M; Meazza R; Orengo AM; Fabbi M; Borghi M; Ribatti D; Nico B; Carlini B; Pistoia V; Corrias MV; Ferrini S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1625-34. PubMed ID: 18324400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
    Liebscher L; Weißenborn C; Langwisch S; Gohlke BO; Preissner R; Rabinovich GA; Christiansen N; Christiansen H; Zenclussen AC; Fest S
    Cancer Lett; 2021 Jul; 509():105-114. PubMed ID: 33848518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
    Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
    Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
    Stermann A; Huebener N; Seidel D; Fest S; Eschenburg G; Stauder M; Schramm A; Eggert A; Lode HN
    Cancer Immunol Immunother; 2015 Oct; 64(10):1215-27. PubMed ID: 26076666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice.
    Croce M; Corrias MV; Orengo AM; Brizzolara A; Carlini B; Borghi M; Rigo V; Pistoia V; Ferrini S
    Int J Cancer; 2010 Sep; 127(5):1141-50. PubMed ID: 20039320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA minigene vaccination for adjuvant neuroblastoma therapy.
    Lode HN; Huebener N; Zeng Y; Fest S; Weixler S; Gaedicke G
    Ann N Y Acad Sci; 2004 Dec; 1028():113-21. PubMed ID: 15650237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma.
    Berger E; Soldati R; Huebener N; Hohn O; Stermann A; Durmus T; Lobitz S; Zenclussen AC; Christiansen H; Lode HN; Fest S
    Cancer Lett; 2013 May; 331(2):167-73. PubMed ID: 23337288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.
    Fest S; Huebener N; Weixler S; Bleeke M; Zeng Y; Strandsby A; Volkmer-Engert R; Landgraf C; Gaedicke G; Riemer AB; Michalsky E; Jaeger IS; Preissner R; Förster-Wald E; Jensen-Jarolim E; Lode HN
    Cancer Res; 2006 Nov; 66(21):10567-75. PubMed ID: 17079481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments.
    Soldati R; Berger E; Zenclussen AC; Jorch G; Lode HN; Salatino M; Rabinovich GA; Fest S
    Int J Cancer; 2012 Sep; 131(5):1131-41. PubMed ID: 22020795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma.
    Huebener N; Fest S; Hilt K; Schramm A; Eggert A; Durmus T; Woehler A; Stermann A; Bleeke M; Baykan B; Weixler S; Gaedicke G; Lode HN
    Mol Cancer Ther; 2009 Aug; 8(8):2392-401. PubMed ID: 19671753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    Marx M; Zumpe M; Troschke-Meurer S; Shah D; Lode HN; Siebert N
    PLoS One; 2018; 13(11):e0207320. PubMed ID: 30452438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.
    Huebener N; Lange B; Lemmel C; Rammensee HG; Strandsby A; Wenkel J; Jikai J; Zeng Y; Gaedicke G; Lode HN
    Cancer Lett; 2003 Jul; 197(1-2):211-7. PubMed ID: 12880984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
    Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.
    Pertl U; Luster AD; Varki NM; Homann D; Gaedicke G; Reisfeld RA; Lode HN
    J Immunol; 2001 Jun; 166(11):6944-51. PubMed ID: 11359856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice.
    Kasamatsu J; Takahashi S; Azuma M; Matsumoto M; Morii-Sakai A; Imamura M; Teshima T; Takahashi A; Hirohashi Y; Torigoe T; Sato N; Seya T
    Immunobiology; 2015 Jan; 220(1):74-82. PubMed ID: 25257859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.